Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00866970

NCT00866970
Completed Phase 2 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC) that cannot be cured by other treatments, including surgery
  • You have lost at least 5% of your body weight in the past 3 months (for example, if you weigh 150 lbs, this would mean losing at least 7.5 lbs)
  • A blood test has shown that you have raised levels of a protein called C-reactive protein (CRP), which is a sign of inflammation in the body (confirm with trial site)
  • Your doctor expects you to live for at least 12 weeks

Who may not be able to join:

  • You have had chemotherapy, large-area radiotherapy, or surgery to treat your cancer within the last 30 days
  • A recent blood test showed that certain liver enzymes (called AST and ALT) are significantly above the normal range (confirm with trial site)
  • A recent blood test showed that your red blood cell levels (haemoglobin) are too low, which may be a sign of anaemia (confirm with trial site)
  • You have a history of tuberculosis (TB) or currently have an active TB infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 2
Sponsor
CSL Behring
Registry
clinicaltrials_gov
Start date
1 September 2008
Est. completion
1 August 2009

Where this trial is recruiting

🇦🇺 Australia 🇨🇦 Canada 🇬🇪 Georgia 🇮🇳 India 🇳🇿 New Zealand 🇵🇱 Poland 🇷🇴 Romania 🇷🇺 Russia 🇷🇸 Serbia

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in Safety parameters.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov